News | HealthLeaders

Campaign to End HIV and Five Other Takeaways from Trump's State of the Union

February 6, 2019

John Kelliher discussed President Trump’s comments on healthcare and proposals on international reference pricing for Medicare Part B drugs and the use of rebates between drugmakers and Pharmacy Benefit Managers in Medicare Part D.

Read the article.


Related Professionals

John J. Kelliher

Managing Director

Washington, DC
Federal Policy